{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T23:43:49Z","timestamp":1792799029938,"version":"4.5.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,12,8]],"date-time":"2022-12-08T00:00:00Z","timestamp":1670457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,12,8]],"date-time":"2022-12-08T00:00:00Z","timestamp":1670457600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["U01MH111826, R61MH125126, R01119285"],"award-info":[{"award-number":["U01MH111826, R61MH125126, R01119285"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Although electroconvulsive therapy (ECT) is an effective treatment for depression, ECT cognitive impairment remains a major concern. The neurobiological underpinnings and mechanisms underlying ECT antidepressant and cognitive impairment effects remain unknown. This investigation aims to identify ECT antidepressant-response and cognitive-impairment multimodal brain networks and assesses whether they are associated with the ECT-induced electric field (E-field) with an optimal pulse amplitude estimation.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A single site clinical trial focused on amplitude (600, 700, and 800 mA) included longitudinal multimodal imaging and clinical and cognitive assessments completed before and immediately after the ECT series (<jats:italic>n<\/jats:italic> = 54) for late-life depression. Another two independent validation cohorts (<jats:italic>n<\/jats:italic> = 84, <jats:italic>n<\/jats:italic> = 260) were included. Symptom and cognition were used as references to supervise fMRI and sMRI fusion to identify ECT antidepressant-response and cognitive-impairment multimodal brain networks. Correlations between ECT-induced E-field within these two networks and clinical and cognitive outcomes were calculated. An optimal pulse amplitude was estimated based on E-field within antidepressant-response and cognitive-impairment networks.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Decreased function in the superior orbitofrontal cortex and caudate accompanied with increased volume in medial temporal cortex showed covarying functional and structural alterations in both antidepressant-response and cognitive-impairment networks. Volume increases in the hippocampal complex and thalamus were antidepressant-response specific, and functional decreases in the amygdala and hippocampal complex were cognitive-impairment specific, which were validated in two independent datasets. The E-field within these two networks showed an inverse relationship with HDRS reduction and cognitive impairment. The optimal E-filed range as [92.7\u2013113.9] V\/m was estimated to maximize antidepressant outcomes without compromising cognitive safety.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The large degree of overlap between antidepressant-response and cognitive-impairment networks challenges parameter development focused on precise E-field dosing with new electrode placements. The determination of the optimal individualized ECT amplitude within the antidepressant and cognitive networks may improve the treatment benefit\u2013risk ratio.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Trial registration<\/jats:title>\n                <jats:p>ClinicalTrials.gov Identifier: NCT02999269.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12916-022-02678-6","type":"journal-article","created":{"date-parts":[[2022,12,8]],"date-time":"2022-12-08T20:04:46Z","timestamp":1670529886000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Links between electroconvulsive therapy responsive and cognitive impairment multimodal brain networks in late-life major depressive disorder"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3486-2277","authenticated-orcid":false,"given":"Shile","family":"Qi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vince D.","family":"Calhoun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daoqiang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-De","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine L.","family":"Narr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvette","family":"Sheline","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shawn M.","family":"McClintock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongtao","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel","family":"Upston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Sui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher C.","family":"Abbott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,12,8]]},"reference":[{"key":"2678_CR1","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1016\/S0140-6736(03)12705-5","volume":"361","author":"UK ECT Review Group","year":"2003","unstructured":"UK ECT Review Group. Efficacy and safety of electroconvulsive therapy in depressive disorder: a systematic review and meta-analysis. Lancet. 2003;361:799\u2013808.","journal-title":"Lancet."},{"issue":"7","key":"2678_CR2","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1001\/jamapsychiatry.2018.0768","volume":"75","author":"EL Ross","year":"2018","unstructured":"Ross EL, Zivin K, Maixner DF. Cost-effectiveness of electroconvulsive therapy vs pharmacotherapy\/psychotherapy for treatment-resistant depression in the United States. JAMA Psychiatry. 2018;75(7):713\u201322.","journal-title":"JAMA Psychiatry"},{"issue":"12","key":"2678_CR3","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.1176\/ajp.156.12.1865","volume":"156","author":"JD Tew Jr","year":"1999","unstructured":"Tew JD Jr, Mulsant BH, Haskett RF, Prudic J, Thase ME, Crowe RR, et al. Acute efficacy of ECT in the treatment of major depression in the old-old. Am J Psychiatry. 1999;156(12):1865\u201370.","journal-title":"Am J Psychiatry"},{"issue":"4","key":"2678_CR4","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1097\/00019442-200111000-00006","volume":"9","author":"MK O'Connor","year":"2001","unstructured":"O'Connor MK, Knapp R, Husain M, Rummans TA, Petrides G, Smith G, et al. The influence of age on the response of major depression to electroconvulsive therapy: a C.O.R.E. Report. Am J Geriatr Psychiatry. 2001;9(4):382\u201390.","journal-title":"Am J Geriatr Psychiatry"},{"issue":"12","key":"2678_CR5","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1001\/archpsyc.1975.01760300095008","volume":"32","author":"LR Squire","year":"1975","unstructured":"Squire LR, Chace PM. Memory functions six to nine months after electroconvulsive therapy. Arch Gen Psychiatry. 1975;32(12):1557\u201364.","journal-title":"Arch Gen Psychiatry"},{"key":"2678_CR6","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2021.608857","volume":"12","author":"VJ Erchinger","year":"2021","unstructured":"Erchinger VJ, Ersland L, Aukland SM, Abbott CC, Oltedal L. Magnetic resonance spectroscopy in depressed subjects treated with electroconvulsive therapy-a systematic review of literature. Front Psychiatry. 2021;12:608857.","journal-title":"Front Psychiatry"},{"issue":"6","key":"2678_CR7","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1038\/mp.2015.69","volume":"21","author":"L Schmaal","year":"2016","unstructured":"Schmaal L, Veltman DJ, van Erp TGM, Samann PG, Frodl T, Jahanshad N, et al. Subcortical brain alterations in major depressive disorder: findings from the ENIGMA Major Depressive Disorder working group. Mol Psychiatry. 2016;21(6):806\u201312.","journal-title":"Mol Psychiatry"},{"issue":"1","key":"2678_CR8","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/sj.npp.1301574","volume":"33","author":"C Pittenger","year":"2008","unstructured":"Pittenger C, Duman RS. Stress, depression, and neuroplasticity: a convergence of mechanisms. Neuropsychopharmacology. 2008;33(1):88\u2013109.","journal-title":"Neuropsychopharmacology."},{"key":"2678_CR9","doi-asserted-by":"crossref","unstructured":"Yang H, Chen X, Chen ZB, Li L, Li XY, Castellanos FX, et al. Disrupted intrinsic functional brain topology in patients with major depressive disorder. Mol Psychiatry. 2021;26(12):7363\u201371.","DOI":"10.1038\/s41380-021-01247-2"},{"issue":"7","key":"2678_CR10","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1248\/bpb.34.939","volume":"34","author":"E Segi-Nishida","year":"2011","unstructured":"Segi-Nishida E. Exploration of new molecular mechanisms for antidepressant actions of electroconvulsive seizure. Biol Pharm Bull. 2011;34(7):939\u201344.","journal-title":"Biol Pharm Bull"},{"issue":"3","key":"2678_CR11","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1073\/pnas.1321399111","volume":"111","author":"J Dukart","year":"2014","unstructured":"Dukart J, Regen F, Kherif F, Colla M, Bajbouj M, Heuser I, et al. Electroconvulsive therapy-induced brain plasticity determines therapeutic outcome in mood disorders. Proc Natl Acad Sci U S A. 2014;111(3):1156\u201361.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2678_CR12","doi-asserted-by":"crossref","unstructured":"Abbott CC, Jones, TR, Lemke, NT, Gallegos, P, McClintock SM, Mayer AR, Bustillo, J, Calhoun VD. Hippocampal structural and functional changes associated with electroconvulsive therapy response. Translational Psychiatry. 2014. (In Press).","DOI":"10.1038\/tp.2014.124"},{"issue":"5","key":"2678_CR13","volume":"40","author":"F Bouckaert","year":"2015","unstructured":"Bouckaert F, De Winter FL, Emsell L, Dols A, Rhebergen D, Wampers M, et al. Grey matter volume increase following electroconvulsive therapy in patients with late life depression: a longitudinal MRI study. J Psychiatry Neurosci. 2015;40(5):140322.","journal-title":"J Psychiatry Neurosci"},{"issue":"4","key":"2678_CR14","first-page":"327","volume":"2","author":"ST Wilkinson","year":"2017","unstructured":"Wilkinson ST, Sanacora G, Bloch MH. Hippocampal volume changes following electroconvulsive therapy: a systematic review and meta-analysis. Biol Psychiatry Cogn Neurosci Neuroimaging. 2017;2(4):327\u201335.","journal-title":"Biol Psychiatry Cogn Neurosci Neuroimaging"},{"issue":"1","key":"2678_CR15","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1192\/bjp.2017.11","volume":"212","author":"A Takamiya","year":"2018","unstructured":"Takamiya A, Chung JK, Liang KC, Graff-Guerrero A, Mimura M, Kishimoto T. Effect of electroconvulsive therapy on hippocampal and amygdala volumes: systematic review and meta-analysis. Br J Psychiatry. 2018;212(1):19\u201326.","journal-title":"Br J Psychiatry"},{"key":"2678_CR16","doi-asserted-by":"crossref","unstructured":"Ousdal OT, Argyelan M, Narr KL, Abbott C, Wade B, Vandenbulcke M, et al. Brain changes induced by electroconvulsive therapy are broadly distributed. Biol Psychiatry. 2019;87(5):451\u201361.","DOI":"10.1016\/j.biopsych.2019.07.010"},{"issue":"8","key":"2678_CR17","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1016\/j.biopsych.2018.05.017","volume":"84","author":"L Oltedal","year":"2018","unstructured":"Oltedal L, Narr KL, Abbott C, Anand A, Argyelan M, Bartsch H, et al. Volume of the human hippocampus and clinical response following electroconvulsive therapy. Biol Psychiatry. 2018;84(8):574\u201381.","journal-title":"Biol Psychiatry"},{"issue":"2","key":"2678_CR18","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1097\/00124509-200106000-00008","volume":"17","author":"L Rami-Gonzalez","year":"2001","unstructured":"Rami-Gonzalez L, Bernardo M, Boget T, Salamero M, Gil-Verona JA, Junque C. Subtypes of memory dysfunction associated with ECT: characteristics and neurobiological bases. J ECT. 2001;17(2):129\u201335.","journal-title":"J ECT"},{"issue":"6","key":"2678_CR19","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1016\/j.biopsych.2010.06.009","volume":"68","author":"M Semkovska","year":"2010","unstructured":"Semkovska M, McLoughlin DM. Objective cognitive performance associated with electroconvulsive therapy for depression: a systematic review and meta-analysis. Biol Psychiatry. 2010;68(6):568\u201377.","journal-title":"Biol Psychiatry"},{"issue":"4","key":"2678_CR20","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1176\/appi.ajp.2015.15030372","volume":"173","author":"M Semkovska","year":"2016","unstructured":"Semkovska M, Landau S, Dunne R, Kolshus E, Kavanagh A, Jelovac A, et al. Bitemopral versus high-dose unilateral twice-weekly electroconvulsive therapy for depression (EFFECT-Dep): a pragmatic, randomized, non-inferiority trial. Am J Psychiatr. 2016;173(4):408\u201317.","journal-title":"Am J Psychiatr"},{"issue":"9","key":"2678_CR21","doi-asserted-by":"publisher","first-page":"e1092","DOI":"10.4088\/JCP.14r09145","volume":"76","author":"P-C Tor","year":"2015","unstructured":"Tor P-C, Bautovich A, Wang M-J, Martin D, Harvey SB, Loo C. A systematic review and meta-analysis of brief versus ultrabrief right unilateral electroconvulsive therapy for depression. J Clin Psychiatry. 2015;76(9):e1092\u2013e8.","journal-title":"J Clin Psychiatry"},{"issue":"2","key":"2678_CR22","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1097\/YCT.0000000000000483","volume":"34","author":"I van Oostrom","year":"2018","unstructured":"van Oostrom I, van Eijndhoven P, Butterbrod E, van Beek MH, Janzing J, Donders R, et al. Decreased cognitive functioning after electroconvulsive therapy is related to increased hippocampal volume: exploring the role of brain plasticity. J ECT. 2018;34(2):117\u201323.","journal-title":"J ECT"},{"key":"2678_CR23","doi-asserted-by":"crossref","unstructured":"Gbyl K, Stottrup MM, Mitta Raghava J, Song XJ, Videbech P. Hippocampal volume and memory impairment after electroconvulsive therapy in patients with depression. Acta Psychiatr Scand. 2020;143(3):238\u201352.","DOI":"10.1111\/acps.13259"},{"issue":"3","key":"2678_CR24","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1097\/YCT.0b013e3181e48165","volume":"26","author":"AV Peterchev","year":"2010","unstructured":"Peterchev AV, Rosa MA, Deng ZD, Prudic J, Lisanby SH. Electroconvulsive therapy stimulus parameters: rethinking dosage. J ECT. 2010;26(3):159\u201374.","journal-title":"J ECT"},{"issue":"1","key":"2678_CR25","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1109\/TNSRE.2014.2339014","volume":"23","author":"ZD Deng","year":"2015","unstructured":"Deng ZD, Lisanby SH, Peterchev AV. Effect of anatomical variability on electric field characteristics of electroconvulsive therapy and magnetic seizure therapy: a parametric modeling study. IEEE Trans Neural Syst Rehabil Eng. 2015;23(1):22\u201331.","journal-title":"IEEE Trans Neural Syst Rehabil Eng"},{"issue":"3","key":"2678_CR26","doi-asserted-by":"publisher","first-page":"2110","DOI":"10.1016\/j.neuroimage.2011.10.029","volume":"59","author":"WH Lee","year":"2012","unstructured":"Lee WH, Deng ZD, Kim TS, Laine AF, Lisanby SH, Peterchev AV. Regional electric field induced by electroconvulsive therapy in a realistic finite element head model: influence of white matter anisotropic conductivity. NeuroImage. 2012;59(3):2110\u201323.","journal-title":"NeuroImage."},{"key":"2678_CR27","doi-asserted-by":"crossref","unstructured":"Fridgeirsson EA, Deng ZD, Denys D, van Waarde JA, van Wingen GA. Electric field strength induced by electroconvulsive therapy is associated with clinical outcome. Neuroimage-Clin. 2021;30:102581.","DOI":"10.1016\/j.nicl.2021.102581"},{"key":"2678_CR28","doi-asserted-by":"crossref","unstructured":"Argyelan M, Oltedal L, Deng ZD, Wade B, Bikson M, Joanlanne A, et al. Electric field causes volumetric changes in the human brain. eLife. 2019;8:e49115.","DOI":"10.7554\/eLife.49115"},{"key":"2678_CR29","doi-asserted-by":"crossref","unstructured":"Deng ZD, Argyelan M, Miller J, Quinn DK, Lloyd M, Jones TR, et al. Electroconvulsive therapy, electric field, neuroplasticity, and clinical outcomes. Mol Psychiatry. 2022;27:1676\u201382.","DOI":"10.1038\/s41380-021-01380-y"},{"issue":"4","key":"2678_CR30","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1097\/YCT.0b013e3182a4b4a7","volume":"29","author":"ZD Deng","year":"2013","unstructured":"Deng ZD, Lisanby SH, Peterchev AV. Controlling stimulation strength and focality in electroconvulsive therapy via current amplitude and electrode size and spacing: comparison with magnetic seizure therapy. J ECT. 2013;29(4):325\u201335.","journal-title":"J ECT"},{"issue":"3","key":"2678_CR31","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1016\/j.brs.2020.02.020","volume":"13","author":"PCR Mulders","year":"2020","unstructured":"Mulders PCR, Llera A, Beckmann CF, Vandenbulcke M, Stek M, Sienaert P, et al. Structural changes induced by electroconvulsive therapy are associated with clinical outcome. Brain Stimul. 2020;13(3):696\u2013704.","journal-title":"Brain Stimul"},{"issue":"7","key":"2678_CR32","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1002\/hbm.24910","volume":"41","author":"S Qi","year":"2020","unstructured":"Qi S, Abbott CC, Narr KL, Jiang R, Upston J, McClintock SM, et al. Electroconvulsive therapy treatment responsive multimodal brain networks. Hum Brain Mapp. 2020;41(7):1775\u201385.","journal-title":"Hum Brain Mapp"},{"issue":"2","key":"2678_CR33","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1097\/YCT.0000000000000137","volume":"30","author":"SM McClintock","year":"2014","unstructured":"McClintock SM, Choi J, Deng ZD, Appelbaum LG, Krystal AD, Lisanby SH. Multifactorial determinants of the neurocognitive effects of electroconvulsive therapy. J ECT. 2014;30(2):165\u201376.","journal-title":"J ECT"},{"key":"2678_CR34","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.neuroimage.2016.11.052","volume":"154","author":"K Murphy","year":"2017","unstructured":"Murphy K, Fox MD. Towards a consensus regarding global signal regression for resting state functional connectivity MRI. Neuroimage. 2017;154:169\u201373.","journal-title":"Neuroimage."},{"issue":"3","key":"2678_CR35","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1016\/j.neuroimage.2008.09.036","volume":"44","author":"K Murphy","year":"2009","unstructured":"Murphy K, Birn RM, Handwerker DA, Jones TB, Bandettini PA. The impact of global signal regression on resting state correlations: are anti-correlated networks introduced? Neuroimage. 2009;44(3):893\u2013905.","journal-title":"Neuroimage."},{"key":"2678_CR36","volume-title":"Delis Kaplan executive function system","author":"DC Delis","year":"2001","unstructured":"Delis DC, Kaplan E, J K. Delis Kaplan executive function system. San Antonio: The Psychological Corporation; 2001."},{"issue":"2","key":"2678_CR37","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.jagp.2020.06.008","volume":"29","author":"CC Abbott","year":"2021","unstructured":"Abbott CC, Quinn D, Miller J, Ye E, Iqbal S, Lloyd M, et al. Electroconvulsive therapy pulse amplitude and clinical outcomes. Am J Geriatr Psychiatry. 2021;29(2):166\u201378.","journal-title":"Am J Geriatr Psychiatry"},{"key":"2678_CR38","volume-title":"Test of premorbid functioning","author":"D Wechsler","year":"2009","unstructured":"Wechsler D. Test of premorbid functioning. San Antonio: The Psychological Corporation; 2009."},{"key":"2678_CR39","doi-asserted-by":"crossref","unstructured":"Abbott CC, Quinn D, Miller J, Ye E, Iqbal S, Lloyd M, et al. Electroconvulsive therapy pulse amplitude and clinical outcomes. Am J Geriatr Psychiatry. 2021;29(2):166\u201378.","DOI":"10.1016\/j.jagp.2020.06.008"},{"key":"2678_CR40","first-page":"222","volume":"2015","author":"A Thielscher","year":"2015","unstructured":"Thielscher A, Antunes A, Saturnino GB. Field modeling for transcranial magnetic stimulation: a useful tool to understand the physiological effects of TMS? Annu Int Conf IEEE Eng Med Biol Soc. 2015;2015:222\u20135.","journal-title":"Annu Int Conf IEEE Eng Med Biol Soc"},{"issue":"5","key":"2678_CR41","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1038\/npp.2017.165","volume":"43","author":"RT Jiang","year":"2018","unstructured":"Jiang RT, Abbott CC, Jiang TZ, Du YH, Espinoza R, Narr KL, et al. SMRI biomarkers predict electroconvulsive treatment outcomes: accuracy with independent data sets. Neuropsychopharmacology. 2018;43(5):1078\u201387.","journal-title":"Neuropsychopharmacology"},{"issue":"3","key":"2678_CR42","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1093\/brain\/awx366","volume":"141","author":"S Qi","year":"2018","unstructured":"Qi S, Yang X, Zhao L, Calhoun VD, Perrone-Bizzozero N, Liu S, et al. MicroRNA132 associated multimodal neuroimaging patterns in unmedicated major depressive disorder. Brain. 2018;141(3):916\u201326.","journal-title":"Brain."},{"issue":"1","key":"2678_CR43","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1109\/TMI.2017.2725306","volume":"37","author":"S Qi","year":"2018","unstructured":"Qi S, Calhoun VD, van Erp TGM, Bustillo J, Damaraju E, Turner JA, et al. Multimodal fusion with reference: searching for joint neuromarkers of working memory deficits in schizophrenia. IEEE Trans Med Imaging. 2018;37(1):93\u2013105.","journal-title":"IEEE Trans Med Imaging"},{"issue":"8","key":"2678_CR44","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.biopsych.2021.01.011","volume":"90","author":"S Qi","year":"2021","unstructured":"Qi S, Schumann G, Bustillo J, Turner JA, Jiang R, Zhi D, et al. Reward processing in novelty seekers: a transdiagnostic psychiatric imaging biomarker. Biol Psychiatry. 2021;90(8):529\u201339.","journal-title":"Biol Psychiatry"},{"issue":"1","key":"2678_CR45","doi-asserted-by":"publisher","first-page":"4929","DOI":"10.1038\/s41467-022-32513-8","volume":"13","author":"S Qi","year":"2022","unstructured":"Qi S, Sui J, Pearlson G, Bustillo J, Perrone-Bizzozero NI, Kochunov P, et al. Derivation and utility of schizophrenia polygenic risk associated multimodal MRI frontotemporal network. Nat Commun. 2022;13(1):4929.","journal-title":"Nat Commun"},{"issue":"1","key":"2678_CR46","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1038\/s41398-020-0834-6","volume":"10","author":"S Qi","year":"2020","unstructured":"Qi S, Bustillo J, Turner JA, Jiang R, Zhi D, Fu Z, et al. The relevance of transdiagnostic shared networks to the severity of symptoms and cognitive deficits in schizophrenia: a multimodal brain imaging fusion study. Transl Psychiatry. 2020;10(1):149.","journal-title":"Transl Psychiatry"},{"issue":"14","key":"2678_CR47","doi-asserted-by":"publisher","first-page":"5464","DOI":"10.1073\/pnas.1117206109","volume":"109","author":"JS Perrin","year":"2012","unstructured":"Perrin JS, Merz S, Bennett DM, Currie J, Steele DJ, Reid IC, et al. Electroconvulsive therapy reduces frontal cortical connectivity in severe depressive disorder. Proc Natl Acad Sci U S A. 2012;109(14):5464\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2678_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2020.110178","volume":"108","author":"D Porta-Casteras","year":"2021","unstructured":"Porta-Casteras D, Cano M, Camprodon JA, Loo C, Palao D, Soriano-Mas C, et al. A multimetric systematic review of fMRI findings in patients with MDD receiving ECT. Prog Neuro-Psychopharmacol Biol Psychiatry. 2021;108:110178.","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"issue":"6","key":"2678_CR49","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/j.biopsych.2021.05.023","volume":"91","author":"OT Ousdal","year":"2022","unstructured":"Ousdal OT, Brancati GE, Kessler U, Erchinger V, Dale AM, Abbott C, et al. The neurobiological effects of electroconvulsive therapy studied through magnetic resonance: what have we learned, and where do we go? Biol Psychiatry. 2022;91(6):540\u20139.","journal-title":"Biol Psychiatry"},{"key":"2678_CR50","doi-asserted-by":"crossref","unstructured":"Lisanby SH, McClintock SM, McCall WV, Knapp RG, Cullum CM, Mueller M, et al. Longitudinal neurocognitive effects of combined electroconvulsive therapy (ECT) and pharmacotherapy in major depressive disorder in older adults: phase 2 of the PRIDE study. Am J Geriatr Psychiatry. 2022;30(1):15\u201328.","DOI":"10.1016\/j.jagp.2021.04.006"},{"issue":"5586","key":"2678_CR51","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1038\/264562a0","volume":"264","author":"GW Hesse","year":"1976","unstructured":"Hesse GW, Teyler TJ. Reversible loss of hippocampal long term potentiation following electronconvulsive seizures. Nature. 1976;264(5586):562\u20134.","journal-title":"Nature."},{"issue":"7","key":"2678_CR52","first-page":"1326","volume":"22","author":"D Cordes","year":"2001","unstructured":"Cordes D, Haughton VM, Arfanakis K, Carew JD, Turski PA, Moritz CH, et al. Frequencies contributing to functional connectivity in the cerebral cortex in \"resting-state\" data. Ajnr. 2001;22(7):1326\u201333.","journal-title":"Ajnr."},{"issue":"8","key":"2678_CR53","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1017\/S0033291718002684","volume":"49","author":"T Bai","year":"2019","unstructured":"Bai T, Wei Q, Xie W, Wang A, Wang J, Ji GJ, et al. Hippocampal-subregion functional alterations associated with antidepressant effects and cognitive impairments of electroconvulsive therapy. Psychol Med. 2019;49(8):1357\u201364.","journal-title":"Psychol Med"},{"issue":"2","key":"2678_CR54","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.brs.2008.03.001","volume":"1","author":"HA Sackeim","year":"2008","unstructured":"Sackeim HA, Prudic J, Nobler MS, Fitzsimons L, Lisanby SH, Payne N, et al. Effects of pulse width and electrode placement on the efficacy and cognitive effects of electroconvulsive therapy. Brain Stimul. 2008;1(2):71\u201383.","journal-title":"Brain Stimul"},{"issue":"3","key":"2678_CR55","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.brs.2013.03.004","volume":"6","author":"Z Nahas","year":"2013","unstructured":"Nahas Z, Short B, Burns C, Archer M, Schmidt M, Prudic J, et al. A feasibility study of a new method for electrically producing seizures in man: focal electrically administered seizure therapy [FEAST]. Brain Stimul. 2013;6(3):403\u20138.","journal-title":"Brain Stimul"},{"issue":"2","key":"2678_CR56","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1038\/s41386-019-0515-4","volume":"45","author":"ZJ Daskalakis","year":"2020","unstructured":"Daskalakis ZJ, Dimitrova J, McClintock SM, Sun Y, Voineskos D, Rajji TK, et al. Magnetic seizure therapy (MST) for major depressive disorder. Neuropsychopharmacology. 2020;45(2):276\u201382.","journal-title":"Neuropsychopharmacology."},{"issue":"6184","key":"2678_CR57","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1126\/science.1248903","volume":"344","author":"KG Akers","year":"2014","unstructured":"Akers KG, Martinez-Canabal A, Restivo L, Yiu AP, De Cristofaro A, Hsiang HL, et al. Hippocampal neurogenesis regulates forgetting during adulthood and infancy. Science. 2014;344(6184):598\u2013602.","journal-title":"Science"},{"issue":"1-2","key":"2678_CR58","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.cnr.2004.06.013","volume":"4","author":"HA Sackeim","year":"2004","unstructured":"Sackeim HA. Convulsant and anticonvulsant properties of electroconvulsive therapy: towards a focal form of brain stimulation. Clin Neurosci Res. 2004;4(1-2):39\u201357.","journal-title":"Clin Neurosci Res"},{"key":"2678_CR59","doi-asserted-by":"publisher","unstructured":"Duda M, Iraji A, Ford JM, Lim KO, Mathalon DH, Mueller BA, et al. Spatially constrained ICA enables robust detection of schizophrenia from very short resting-state fMRI data. medRxiv. 2022. https:\/\/doi.org\/10.1101\/2022.03.17.22271783.","DOI":"10.1101\/2022.03.17.22271783"},{"key":"2678_CR60","doi-asserted-by":"crossref","unstructured":"Miller J, Jones T, Upston J, Deng Z, McClintock S, Ryman S, et al. Ictal theta power as an electroconvulsive therapy safety biomarker: a pilot study. J ECT. 2022;38(2):88\u201394.","DOI":"10.1097\/YCT.0000000000000812"}],"updated-by":[{"DOI":"10.1186\/s12916-023-02800-2","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2023,3,29]],"date-time":"2023-03-29T00:00:00Z","timestamp":1680048000000}}],"container-title":["BMC Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-022-02678-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12916-022-02678-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-022-02678-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,29]],"date-time":"2023-03-29T07:06:13Z","timestamp":1680073573000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedicine.biomedcentral.com\/articles\/10.1186\/s12916-022-02678-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,8]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["2678"],"URL":"https:\/\/doi.org\/10.1186\/s12916-022-02678-6","relation":{"correction":[{"id-type":"doi","id":"10.1186\/s12916-023-02800-2","asserted-by":"object"}]},"ISSN":["1741-7015"],"issn-type":[{"value":"1741-7015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,8]]},"assertion":[{"value":"31 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 November 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 March 2023","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1186\/s12916-023-02800-2","URL":"https:\/\/doi.org\/10.1186\/s12916-023-02800-2","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors assert that all procedures contributing to this work comply with the ethical standards of the relevant national and institutional committees on human experimentation and with the Helsinki Declaration of 1975, as revised in 2008. All procedures involving human patients were approved by Institutional Review Board and the University of New Mexico Human Research Protections Office (ClinicalTrials.gov Identifier: NCT02999269).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"477"}}